期刊论文详细信息
BMC Medical Genetics
Identification of somatic mutations using whole-exome sequencing in Korean patients with acute myeloid leukemia
Research Article
Hyung-Lae Kim1  Youngil Koh2  Sung-Soo Yoon2  Ji Wan Park3  Seong Gu Heo4  Jong Kwang Kim5  Jongsun Jung6 
[1] Department of Biochemistry, School of Medicine, Ewha Womans University, Seoul, Republic of Korea;Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea;Department of Medical Genetics, College of Medicine, Hallym University, 1 Hallymdaehak-gil, 24252, Chuncheon, Gangwon-do, Republic of Korea;Department of Medical Genetics, College of Medicine, Hallym University, 1 Hallymdaehak-gil, 24252, Chuncheon, Gangwon-do, Republic of Korea;Wide River Institute of Immunology, Seoul National University, Hongcheon, Republic of Korea;Omics Core Lab., National Cancer Center, Goyang, Republic of Korea;The Catholic University, Seoul, Republic of Korea;Syntekabio Inc., Seoul, Republic of Korea;
关键词: Acute myeloid leukemia;    Gene ontology;    Pathway analysis;    Somatic mutation;    Subtype-specific mutation;    Whole-exome sequencing;   
DOI  :  10.1186/s12881-017-0382-y
 received in 2016-01-24, accepted in 2017-02-15,  发布年份 2017
来源: Springer
PDF
【 摘 要 】

BackgroundAcute myeloid leukemia (AML) is a biologically and clinically heterogeneous cancer of the bone marrow that is characterized by the rapid growth of abnormal myeloid cells.MethodsWe performed a mutational analysis to identify AML somatic mutations using the whole-exome sequencing data of 36 tumor-normal sample pairs from Korean patients with de novo AML. We explored the functional impact of the genes identified in the mutational analyses through an integrated Gene Ontology (GO) and pathway analysis.ResultsA total of 11 genes, including NEFH (p = 6.27 × 10−13 and q = 1.18 × 10−8) and TMPRSS13 (p = 1.40 × 10−10 and q = 1.32 × 10−6), also demonstrated q values less than 0.1 in 36 Korean AML patients. Five out of the 11 novel genes have previously been reported to be associated with other cancers. Two gene mutations, CEBPA (p = 5.22 × 10−5) and ATXN3 (p = 9.75 × 10−4), showed statistical significance exclusively in the M2 and M3 subtypes of the French-American-British classifications, respectively. A total of 501 genes harbored 478 missense, 22 nonsense, 93 frameshift indels, and/or three stop codon deletions and these gene mutations significantly enriched GO terms for signal transduction (GO:0007165, p = 1.77 × 10−3), plasma membrane (GO:0005886, p = 3.07 × 10−4), and scaffold protein binding (GO:0097110, p = 8.65 × 10−4). The mitogen-activated protein kinase (hsa04010, 7.67 × 10−4) was the most enriched Kyoto Encyclopedia of Genes and Genomes pathway.ConclusionsMorphological AML subtypes may in part reflect subtype specific patterns of genomic alterations. Following validation, future studies to evaluate the usefulness of these genes in genetic testing for the early diagnosis and prognostic prediction of AML patients would be worthwhile.

【 授权许可】

CC BY   
© The Author(s). 2017

【 预 览 】
附件列表
Files Size Format View
RO202311098309210ZK.pdf 570KB PDF download
【 参考文献 】
  • [1]
  • [2]
  • [3]
  • [4]
  • [5]
  • [6]
  • [7]
  • [8]
  • [9]
  • [10]
  • [11]
  • [12]
  • [13]
  • [14]
  • [15]
  • [16]
  • [17]
  • [18]
  • [19]
  • [20]
  • [21]
  • [22]
  • [23]
  • [24]
  • [25]
  • [26]
  • [27]
  • [28]
  • [29]
  • [30]
  • [31]
  • [32]
  • [33]
  • [34]
  • [35]
  • [36]
  • [37]
  • [38]
  • [39]
  • [40]
  • [41]
  • [42]
  • [43]
  • [44]
  • [45]
  • [46]
  文献评价指标  
  下载次数:8次 浏览次数:0次